Glenmark gets final FDA approval for hydralazine
This article was originally published in Scrip
Executive Summary
Glenmark Generics' US subsidiary has received final approval from the US FDA for its ANDA for hydralazine hydrochloride 10mg, 25mg, 50mg, and 100mg tablets.